1. Academic Validation
  2. An amphipol-stabilized multi-pass transmembrane protein as an immunogen to generate mouse memory B cells against native VMAT2

An amphipol-stabilized multi-pass transmembrane protein as an immunogen to generate mouse memory B cells against native VMAT2

  • FEBS Lett. 2025 Jun 17. doi: 10.1002/1873-3468.70092.
Jiping Yang 1 Tao Liu 1 Xianqing Mai 1 Shengyan Kong 1 Jingjing He 2 Zhenhua Wang 2 Jie Shen 1 Xiaohua He 1 Yongmei Xing 1 Hongwu Qian 2 Pei Tong 1 3
Affiliations

Affiliations

  • 1 School of Basic Medical Sciences, Center for Big Data and Population Health of Institute of Health and Medicine, Anhui Medical University, Hefei, China.
  • 2 The First Affiliated Hospital of USTC, MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, Hefei National Research Center for Interdisciplinary Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • 3 State Key Laboratory of Immune Response and Immunotherapy, Institute of Health and Medicine, Hefei Comprehensive National Science Center, China.
Abstract

Multi-pass transmembrane proteins (MPTPs) are essential for sensing and processing cellular signals and are the primary drug targets of more than half of the approved drugs, the majority being small molecules. However, monoclonal antibodies with favorable properties in modulating MPTPs are rare. Such antibody discovery is limited by the challenging preparation of correctly folded antigens and the generation of antibodies against the natural conformation of MPTPs. Here, we developed an amphipol-trapped antigen as an immunogen and induced efficient mouse memory B cell responses. We generated antibodies unbiasedly by culturing single memory B cells and characterized their specificities. We implemented our strategy to generate high-affinity antibodies against the native conformation of vesicular Monoamine Transporter 2 (VMAT2; also known as SLC18A2), demonstrating the potential use in discovering antibodies against MPTPs for therapeutics.

Keywords

VMAT2; amphipol; memory B cell; monoclonal antibody; multi‐pass transmembrane protein.

Figures
Products